Advisors Asset Management Inc. lifted its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 35.1% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 133,666 shares of the pharmacy operator's stock after purchasing an additional 34,728 shares during the quarter. Advisors Asset Management Inc.'s holdings in CVS Health were worth $8,405,000 as of its most recent SEC filing.
Several other large investors have also added to or reduced their stakes in the stock. MidAtlantic Capital Management Inc. purchased a new stake in shares of CVS Health in the 3rd quarter valued at about $25,000. Livelsberger Financial Advisory bought a new stake in CVS Health during the third quarter valued at approximately $31,000. Crewe Advisors LLC bought a new position in shares of CVS Health in the 1st quarter worth $40,000. Reston Wealth Management LLC bought a new stake in shares of CVS Health during the 3rd quarter worth $32,000. Finally, Kathleen S. Wright Associates Inc. purchased a new stake in CVS Health during the third quarter valued at about $33,000. Institutional investors own 80.66% of the company's stock.
Wall Street Analysts Forecast Growth
CVS has been the topic of several recent research reports. Cantor Fitzgerald reiterated a "neutral" rating and set a $62.00 price objective on shares of CVS Health in a research report on Tuesday, October 1st. Mizuho decreased their price target on shares of CVS Health from $73.00 to $66.00 and set an "outperform" rating on the stock in a research note on Thursday, October 24th. Wells Fargo & Company raised shares of CVS Health from an "equal weight" rating to an "overweight" rating and upped their price objective for the company from $60.00 to $66.00 in a research note on Monday. Royal Bank of Canada decreased their target price on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a research report on Friday, November 15th. Finally, Deutsche Bank Aktiengesellschaft cut their price target on shares of CVS Health from $64.00 to $63.00 and set a "hold" rating for the company in a research report on Friday, August 9th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat.com, CVS Health currently has a consensus rating of "Moderate Buy" and a consensus target price of $72.28.
Get Our Latest Research Report on CVS
CVS Health Stock Down 0.1 %
Shares of CVS stock traded down $0.07 during midday trading on Thursday, reaching $56.76. 1,136,206 shares of the stock were exchanged, compared to its average volume of 11,333,284. The firm has a market cap of $71.43 billion, a PE ratio of 14.42, a price-to-earnings-growth ratio of 0.94 and a beta of 0.55. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The company's 50 day moving average is $59.18 and its two-hundred day moving average is $58.61. CVS Health Co. has a 1 year low of $52.71 and a 1 year high of $83.25.
CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts' consensus estimates of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. During the same period in the prior year, the firm earned $2.21 EPS. The company's revenue was up 6.3% compared to the same quarter last year. On average, equities research analysts predict that CVS Health Co. will post 5.43 EPS for the current year.
CVS Health Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were paid a $0.665 dividend. The ex-dividend date was Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.69%. CVS Health's dividend payout ratio is currently 67.51%.
About CVS Health
(
Free Report)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Read More
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.